Randomized phase II study of cetuximab and bevacizumab in combination with two regimens of paclitaxel and carboplatin in chemonaive patients with stage IIIB/IV non-small-cell lung cancer.

Randomized phase II study of cetuximab and bevacizumab in combination with two regimens of paclitaxel and carboplatin in chemonaive patients with stage IIIB/IV non-small-cell lung cancer. J Thorac Oncol. 2013 Mar; 8(3):338-45.

View in: PubMed

subject areas

Adenocarcinoma
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Carboplatin
Carcinoma, Large Cell
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Cetuximab
Clinical Trials, Phase III as Topic
Female
Follow-Up Studies
Humans
Lung Neoplasms
Male
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Paclitaxel
Prognosis
Survival Rate

authors with profiles

Philip Bonomi